| Source Date | Board Meeting Date | Details |
|
23-Oct-2025
|
28-Oct-2025
|
Inter alia, to consider and approve the proposal for fund raising by way of Issuance of Securities namely Equity Shares, Preference Shares, Warrants, Debentures or other securities through rights issue, qualified institutions placement, preferential issue or any other method as may be permitted under the applicable law.
|
|
09-Oct-2025
|
17-Oct-2025
|
Quarterly Results
|
|
08-Aug-2025
|
14-Aug-2025
|
Inter alia, to consider and approve:- (1) The proposal for raising funds by way of Equity Shares, Debentures or other securities through rights issue, qualified institutions placement, preferential issue or any other method as may be permitted under the applicable law, subject to such regulatory / statutory approvals as may be required.
|
|
14-Jul-2025
|
21-Jul-2025
|
Quarterly Results
|
|
07-May-2025
|
15-May-2025
|
Inter alia, to consider and approve:- 1. The Management Discussion and Analysis Report (MDAR) for the Financial Year 2024-25. 2. The Directors Report and its annexures for the Financial Year 2024-25. 3. The increase in the Authorized Share Capital of the Company. 4. The terms and conditions and other related matters in connection with the Rights Issue of Equity Shares, including the determination of Rights Issue price and related payment mechanism, issue size, rights entitlement ratio, record date, Issue opening and closing date, etc. and to approve the Letter of Offer and other related documents. 5. To consider and fix date, time and venue for convening the 31st Annual General Meeting of the Company.
|
|
15-Apr-2025
|
21-Apr-2025
|
Audited Results
|
|
17-Mar-2025
|
20-Mar-2025
|
Right Issue of Equity Shares & Audited Results
|
|
24-Feb-2025
|
28-Feb-2025
|
Inter alia, to consider and approve:- 1. The proposal for raising funds by way of equity shares or other securities through rights issue, qualified institutions placement, preferential issue or any other method as may be permitted under the applicable law, subject to such regulatory / statutory approvals as may be required. 2. The increase in the authorized share capital of the Company. 3. Fix date, time and venue for convening the Extra- Ordinary General Meeting of the Company.
|
|
14-Jan-2025
|
19-Jan-2025
|
Quarterly Results & Inter alia, shall also consider the proposal for raising of fund by way of equity shares or any other securities through rights issue, qualified institutions placement, preferential issue or any other method as may be permitted under the applicable law, subject to such regulatory/ statutory approvals as may be required
|
|
13-Jan-2025
|
19-Jan-2025
|
Quarterly Results
|